| Ambrosi 1975 |
Separate data for patients diagnosed with PAD stage II according to Fontaine were not available. |
| Baitsch 1986 |
This study compares Ginkgo biloba extract with dextran in patients with PAD stage IV according to Fontaine. |
| Berndt 1987 |
Ginkgo biloba extract is compared with buflomedil. |
| Bohmer 1988 |
(According to Fontaine), diagnosed for more than 1 year. |
| Courbier 1977 |
Separate data for patients diagnosed with PAD stage II according to Fontaine were not available. |
| Frileux 1975 |
Separate data for patients diagnosed with PAD stage II according to Fontaine were not available. |
| Garzya 1981 |
Separate data for patients diagnosed with PAD stage II according to Fontaine were not available. |
| Horsch 1998 |
Ginkgo biloba extract is compared with naftidrofuryl in patients with PAD stage III and IV according to Fontaine. |
| Li 1998 |
Primary aim of this study was to compare diabetic and non‐diabetic PAD patients. |
| Michelini 1998 |
This study compares the combination of Ginkgo biloba extract, magnesium and Levo‐arginine with acetylsalicyl acid. |
| Rudofsky 1987 |
Double blind randomised cross‐over study evaluating the short term effect (60 minutes) of Ginkgo biloba extract versus placebo in patients with PAD stage II according to Fontaine. |
| Sandreau 1989 |
This study only included patients diagnosed with PAD stage III according to Fontaine. |
| Schweizer 1999 |
This study compares two dosages of Ginkgo biloba extract without a placebo group. |